ATE314842T1 - Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder eine vorstufe davon enthalten - Google Patents

Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder eine vorstufe davon enthalten

Info

Publication number
ATE314842T1
ATE314842T1 AT02002974T AT02002974T ATE314842T1 AT E314842 T1 ATE314842 T1 AT E314842T1 AT 02002974 T AT02002974 T AT 02002974T AT 02002974 T AT02002974 T AT 02002974T AT E314842 T1 ATE314842 T1 AT E314842T1
Authority
AT
Austria
Prior art keywords
precursor
cystein
pharmaceutical compositions
compositions containing
containing paracetamol
Prior art date
Application number
AT02002974T
Other languages
English (en)
Inventor
Roger Spencer Jones
Original Assignee
Sinclair Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Ltd filed Critical Sinclair Pharmaceuticals Ltd
Application granted granted Critical
Publication of ATE314842T1 publication Critical patent/ATE314842T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02002974T 1993-03-12 1994-03-08 Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder eine vorstufe davon enthalten ATE314842T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939305058A GB9305058D0 (en) 1993-03-12 1993-03-12 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
ATE314842T1 true ATE314842T1 (de) 2006-02-15

Family

ID=10731916

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02002974T ATE314842T1 (de) 1993-03-12 1994-03-08 Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder eine vorstufe davon enthalten
AT94908449T ATE221777T1 (de) 1993-03-12 1994-03-08 Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder einen vorlaeufer davon enthalten

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT94908449T ATE221777T1 (de) 1993-03-12 1994-03-08 Pharmazeutische zusammensetzungen, die paracetamol und l-cystein oder einen vorlaeufer davon enthalten

Country Status (20)

Country Link
US (2) US5716991A (de)
EP (2) EP1210939B1 (de)
JP (1) JPH08507305A (de)
KR (1) KR960700701A (de)
CN (1) CN1118989A (de)
AT (2) ATE314842T1 (de)
AU (1) AU674934B2 (de)
BR (1) BR9406227A (de)
CA (1) CA2157921C (de)
DE (2) DE69431151T2 (de)
DK (1) DK0689434T3 (de)
ES (2) ES2254541T3 (de)
GB (2) GB9305058D0 (de)
IL (1) IL108937A (de)
NO (1) NO318493B1 (de)
NZ (1) NZ262168A (de)
PT (1) PT689434E (de)
SG (1) SG48344A1 (de)
WO (1) WO1994020086A1 (de)
ZA (1) ZA941674B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998032434A1 (en) * 1997-01-29 1998-07-30 Chong Kun Dang Corp. New analgesic composition
WO2001068069A2 (en) * 2000-03-15 2001-09-20 King's College London Pharmaceutical composition comprising paracetamol
KR100379155B1 (ko) * 2000-07-18 2003-04-08 삼진제약주식회사 새로운 진통제 조성물
US6623754B2 (en) 2001-05-21 2003-09-23 Noveon Ip Holdings Corp. Dosage form of N-acetyl cysteine
US20080188439A1 (en) * 2006-10-26 2008-08-07 Salhanick Steven D Directed metabolism of compounds by glucuronidation and sulfonation donors to decrease toxicity
ITMI20080187A1 (it) * 2008-02-07 2009-08-08 Velleja Res Srl Formulazioni di amminoacidi per la prevenzione del danno epatico da paracetamolo
US20110014285A1 (en) * 2009-07-15 2011-01-20 Herzenberg Leonore A N-acetyl cysteine compositions and methods to improve the therapeutic efficacy of acetaminophen
ITMI20130874A1 (it) * 2013-05-29 2014-11-30 Zambon Spa Compresse deglutibili di n-acetilcisteina

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3200039A (en) * 1962-05-28 1965-08-10 Pfizer & Co C Non-granulated tablets with 20% sorbitol in a particle size of from about 100mu to about 2000mu
GB1287431A (en) * 1969-04-16 1972-08-31 Aspro Nicholas Ltd Improvements in pharmaceutical formulations
GB1390032A (en) * 1971-08-27 1975-04-09 Sterling Winthrop Group Ltd Pharmaceutical compositions
GB1410909A (en) * 1971-10-26 1975-10-22 Sterling Winthrop Group Ltd Pharmaceutical compositions
GB1463505A (en) * 1973-11-21 1977-02-02 Nat Res Dev Pharmaceutical compositions
GB1583602A (en) * 1977-05-26 1981-01-28 Sterwin Ag N-acetyl-para-aminophenyl-n'-acetyl-amino-thioalkanoic acid ester derivatives
EP0040472B1 (de) * 1980-05-20 1986-01-29 Mallinckrodt, Inc. (a Delaware corporation) Trockenpulverisierte N-Acetyl-p-aminophenol-Zusammensetzungen und Verfahren zu deren Herstellung
US4439453A (en) * 1980-12-22 1984-03-27 Monsanto Company Directly compressible acetaminophen granulation
IE55579B1 (en) * 1982-07-06 1990-11-07 Sterwin Ag Processes for preparing tablets by a modified'wet-granulation'technique
US4600579A (en) * 1983-06-07 1986-07-15 Mallinckrodt, Inc. N-acetyl-p-aminophenol compositions containing partially gelatinized starch and method for preparing same
US4760093A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5037658A (en) * 1989-09-14 1991-08-06 Hoechst-Roussel Pharmaceuticals, Inc. Direct dry compressible acetaminophen composition
ATE125702T1 (de) * 1990-10-19 1995-08-15 Spirig Ag Feste, schnell-lösliche arzneimittelzubereitung enthaltend s-(carboxymethyl)-l-cystein und/oder n-acetylcystein.
US5474757A (en) * 1992-10-16 1995-12-12 Rutgers University Prevention of acetaminophen overdose toxicity with organosulfur compounds
FR2708602B1 (fr) * 1993-08-02 1995-10-06 Oreal Procédé d'extraction des composés malodorants présents dans une formulation contenant au moins un composé comportant un groupe thiol et compositions désodorisées ainsi obtenues.
US5370878A (en) * 1993-09-30 1994-12-06 Hallmark Pharmaceuticals, Inc. Method for preparing a direct compression granulated acetaminophen composition
JPH07130367A (ja) * 1993-10-29 1995-05-19 Sony Corp リチウム二次電池用正極活物質の製造方法

Also Published As

Publication number Publication date
DK0689434T3 (da) 2002-12-02
DE69434600D1 (de) 2006-03-30
NO953515L (no) 1995-09-07
ES2254541T3 (es) 2006-06-16
CN1118989A (zh) 1996-03-20
SG48344A1 (en) 1998-04-17
ATE221777T1 (de) 2002-08-15
EP0689434A1 (de) 1996-01-03
CA2157921C (en) 2006-07-11
WO1994020086A1 (en) 1994-09-15
IL108937A0 (en) 1994-06-24
GB2276319A (en) 1994-09-28
DE69431151D1 (de) 2002-09-12
GB9404427D0 (en) 1994-04-20
EP1210939A3 (de) 2002-08-07
DE69434600T2 (de) 2006-08-24
ZA941674B (en) 1995-09-11
PT689434E (pt) 2002-12-31
US5716991A (en) 1998-02-10
ES2176238T3 (es) 2002-12-01
CA2157921A1 (en) 1994-09-15
IL108937A (en) 1999-10-28
NO318493B1 (no) 2005-03-29
EP1210939A2 (de) 2002-06-05
GB9305058D0 (en) 1993-04-28
DE69431151T2 (de) 2002-12-12
US5852055A (en) 1998-12-22
BR9406227A (pt) 1995-12-12
EP1210939B1 (de) 2006-01-04
NZ262168A (en) 1997-05-26
AU6148794A (en) 1994-09-26
NO953515D0 (no) 1995-09-07
JPH08507305A (ja) 1996-08-06
GB2276319B (en) 1997-01-15
EP0689434B1 (de) 2002-08-07
AU674934B2 (en) 1997-01-16
KR960700701A (ko) 1996-02-24

Similar Documents

Publication Publication Date Title
YU174490A (sh) Novi estri tienil-karboksilne kiseline sa aminoalkoholima, njihova kvaterna jedinjenja kao i pripremanje i primena tih jedinjenja
DE3588095D1 (de) Polypeptid, dessen Verfahren zur Herstellung und dieses enthaltende pharmazeutische Zusammensetzung und deren Benutzung
BR9404330A (pt) Dispositivo para misturar uma composição farmacêutica com um outro agente, processo para preparar um preparado farmacêutico mediante a mistura de uma composição farmacêutica com um agente, e, processo para a aplicação oral de um preparado farmacêutico.
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
PL314187A1 (en) Novel derivatives of pyrazine carboxamide, method of obtaining them and their application in pharmaceutical composition
HU903961D0 (en) Process for producing 11-beta-aryl-4-oestrenes and pharmaceutical preparatives containing these compounds
ATE95070T1 (de) Pharmazeutische zusammensetzung mit gehalt an einer mischung von kollagen und einem antiseptischen und/oder entzuendungshemmenden wirkstoff und verfahren zu ihrer herstellung.
DE69034226D1 (de) Herstellungsverfahren von Huperzine A und deren Analogen und Verbindungen nützlich dazu
UA12648A (uk) Спосіб одержаhhя твердої лікарської форми
DE69434600D1 (de) Pharmazeutische Zusammensetzungen, die Paracetamol und L-Cystein oder eine Vorstufe davon enthalten
ES2054843T3 (es) Compuesto organomineral de vanadilo, procedimiento para obtener tal compuesto, composicion farmaceutica que contiene dicho compuesto organomineral.
HUT54988A (en) Process for producing substituted n-(quinolin-2-ylmethoxy)-benzylsulfonylureas and pharmaceutical compositions comprising such compounds
RU94046463A (ru) Антиандрогенное соединение, предшественник лекарственного средства, фармацевтические композиции, способ лечения или предотвращения заболеваний
ATE81118T1 (de) Strontiumsalz, verfahren zu dessen herstellung und arzneimittel, die es enthalten.
PT1123937E (pt) Substancia gm-95 processo para a sua preparacao e a sua utilizacao
ECSP951385A (es) Composiciones farmaceuticas paracetamol con metionina
HUT57746A (en) Process for producing new 1,3-oxazines and pharmaceutical compositions comprising same
ATE12241T1 (de) Leukotrienaehnliche verbindungen, deren herstellung und verwendung in pharmazeutischen zusammensetzungen.
MX9634A (es) Procedimiento para la preparacion de un activador plasminogeno hibrido, producto obtenido, mutante del mismo, vector hibrido para modificar adn y composicion farmaceutica que incluye el activador de plasminogeno.
PT88578A (pt) Process for the manufacture of 2,6-methanopyrrolo-3-benzazocines of intermediates useful for their manufacture and of pharmaceutical compositions containing them
ZA80619B (en) New laevorotatory basic derivative of 9,10-ethanoanthracene,process for the manufacture thereof,pharmaceutical compositions containing this compound and their use
UA32939A (uk) Сульфокамфокаїн, спосіб його виготовлення і спосіб підготовки обладнання для виготовлення сульфокамфокаїну

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1210939

Country of ref document: EP

EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee